← Evidence map

ArticleResearch square2026

TRIM29 is Critical for Bladder Cancer Progression and Modulates the Tumor-Immune Niche.

Phillip Palmbos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42239777